{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T09:12:30Z","timestamp":1788685950818,"version":"build-2803163510"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbiological Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.micres.2026.128682","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T06:51:54Z","timestamp":1786690314000},"page":"128682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Synthetic biology strategies for engineering microbial therapeutics in metabolic diseases and cancer"],"prefix":"10.1016","volume":"313","author":[{"given":"Boniface Adakole","family":"Onoja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel A.","family":"Agada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waheeb Sami","family":"Aggad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailah M.","family":"Almohaimeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4105-8615","authenticated-orcid":false,"given":"Esther Ugo","family":"Alum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasim Sakran","family":"Abass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1485-5776","authenticated-orcid":false,"given":"Benedict Nnachi","family":"Alum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1129-1785","authenticated-orcid":false,"given":"Daniel Ejim","family":"Uti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micres.2026.128682_bib1","unstructured":"4D pharma plc: A Phase I\/II Open Label, Safety And Preliminary Efficacy Study of MRx0518 In Combination With Pembrolizumab In Patients With Advanced Malignancies Who Have Progressed On PD-1\/PD-L1 Inhibitors. clinicaltrials.gov (2023)."},{"key":"10.1016\/j.micres.2026.128682_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/aem.01983-25","article-title":"The plasmid-host fitness landscape: a new paradigm for predicting the fate of mobile resistance","volume":"92","author":"Abdulqadir","year":"2026","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.micres.2026.128682_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms12030430","article-title":"Next-generation probiotics as novel therapeutics for improving human health: current trends and future perspectives","volume":"12","author":"Abouelela","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.micres.2026.128682_bib4","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.3390\/pharmaceutics14102100","article-title":"Salmonella as a promising curative tool against cancer","volume":"14","author":"Aganja","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.micres.2026.128682_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12934-025-02838-2","article-title":"Bacteria-based immunosuppressive tumor microenvironment reprogramming: a promising dawn in cancer therapy","volume":"24","author":"Akbariqomi","year":"2025","journal-title":"Microb. Cell. Factor."},{"key":"10.1016\/j.micres.2026.128682_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41422-025-01212-6","article-title":"Gut dysbiosis in oncology: a risk factor for immunoresistance","volume":"36","author":"Almonte","year":"2026","journal-title":"Cell. Res."},{"key":"10.1016\/j.micres.2026.128682_bib7","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s40265-021-01499-w","article-title":"A pharmacological and clinical overview of oral semaglutide for the treatment of type 2 diabetes","volume":"81","author":"Andersen","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.micres.2026.128682_bib8","doi-asserted-by":"crossref","DOI":"10.37047\/jos.galenos.2024.2024.104258","article-title":"Application of synthetic antigen-encoded escherichia coli nissle 1917 probiotic-guided PD-1\/CD28 receptor-integrated CAR-T cell therapy as targeted therapy for colorectal cancer: a literature review","author":"Ariawan","year":"2025","journal-title":"J. Oncol. Sci."},{"key":"10.1016\/j.micres.2026.128682_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12967-025-07428-9","article-title":"Dietary interventions and the gut microbiota: a systematic literature review of 80 controlled clinical trials","volume":"24","author":"Aslam","year":"2026","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.micres.2026.128682_bib10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2147\/BTT.S326422","article-title":"Mechanism and applications of CRISPR\/Cas-9-mediated genome editing","volume":"15","author":"Asmamaw","year":"2021","journal-title":"Biol. Targets Ther."},{"key":"10.1016\/j.micres.2026.128682_bib11","doi-asserted-by":"crossref","first-page":"9168","DOI":"10.3390\/ijms25179168","article-title":"Protective mechanisms of vaginal lactobacilli against sexually transmitted viral infections","volume":"25","author":"Avitabile","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micres.2026.128682_bib12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3390\/pharmaceutics17040397","article-title":"Barriers and strategies for oral peptide and protein therapeutics delivery: update on clinical advances","volume":"17","author":"Baral","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.micres.2026.128682_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1331355","article-title":"Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours","volume":"14","author":"Bigos","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.micres.2026.128682_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115663","article-title":"Bioinspired approaches to encapsulate and deliver bacterial live biotherapeutic products","volume":"225","author":"Brittain","year":"2025","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.micres.2026.128682_bib15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41579-022-00833-7","article-title":"Microbiota-mediated colonization resistance: mechanisms and regulation","volume":"21","author":"Caballero-Flores","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.micres.2026.128682_bib16","first-page":"1","article-title":"Lactococcus lactis as an interleukin delivery system for prophylaxis and treatment of inflammatory and autoimmune diseases","author":"Campos","year":"2023","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"10.1016\/j.micres.2026.128682_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2024.1425529","article-title":"Therapeutic applications of synthetic gene\/genetic circuits: a patent review","volume":"12","author":"Carneiro","year":"2024","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.micres.2026.128682_bib18","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.3390\/cancers14092291","article-title":"Hypoxia as a modulator of inflammation and immune response in cancer","volume":"14","author":"Castillo-Rodr\u00edguez","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.micres.2026.128682_bib19","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.2147\/IJN.S516523","article-title":"Recent advances in spatiotemporal manipulation of engineered bacteria for precision cancer therapy","volume":"20","author":"Chang","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.micres.2026.128682_bib20","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/s41467-020-15508-1","article-title":"Developing a new class of engineered live bacterial therapeutics to treat human diseases","volume":"11","author":"Charbonneau","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micres.2026.128682_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125585","article-title":"Engineering advanced bacterial therapy for tumor and inflammatory diseases","volume":"676","author":"Chen","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.micres.2026.128682_bib22","article-title":"The role of immune checkpoint inhibitors in cancer therapy: mechanism and therapeutic advances","volume":"6","author":"Chen","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.micres.2026.128682_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27156615","article-title":"Bacteriophage-based therapeutic, diagnostic, and biocontrol platforms: engineering, evidence, and translational challenges","volume":"27","author":"Chen","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micres.2026.128682_bib24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41522-025-00839-y","article-title":"Microbial regulators of physiological and reproductive health in women of reproductive age: their local, proximal and distal regulatory roles","volume":"11","author":"Cheng","year":"2025","journal-title":"NPJ Biofilms Micro."},{"key":"10.1016\/j.micres.2026.128682_bib25","unstructured":"City of Hope Medical Center: Pilot Study to Evaluate the Biologic Effect of CBM588 in Combination With Nivolumab\/Ipilimumab for Patients With Metastatic Renal Cell Carcinoma. clinicaltrials.gov (2024)."},{"key":"10.1016\/j.micres.2026.128682_bib26","doi-asserted-by":"crossref","first-page":"10672","DOI":"10.3390\/ijms241310672","article-title":"New insights and potential therapeutic interventions in metabolic diseases","volume":"24","author":"Clemente-Su\u00e1rez","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micres.2026.128682_bib27","article-title":"Safety communication- risk of serious adverse reactions due to transmission of multi-drug resistant organisms","year":"2024","journal-title":"FDA"},{"key":"10.1016\/j.micres.2026.128682_bib28","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/s41385-021-00383-w","article-title":"Host\/microbiota interactions in health and diseases\u2014Time for mucosal microbiology!","volume":"14","author":"Daniel","year":"2021","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.micres.2026.128682_bib29","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1089\/crispr.2022.0051","article-title":"Advances in CRISPR delivery methods: perspectives and challenges","volume":"5","author":"Demirci","year":"2022","journal-title":"CRISPR J."},{"key":"10.1016\/j.micres.2026.128682_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2025.107717","article-title":"Age-related oral microbiota dysbiosis and systemic diseases","volume":"205","author":"Deng","year":"2025","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micres.2026.128682_bib31","article-title":"Multifunctional nanoplatforms for tumor microenvironment remodeling: Toward precision and intelligent cancer therapy","volume":"35","author":"Deng","year":"2025","journal-title":"Mater. Today Bio."},{"key":"10.1016\/j.micres.2026.128682_bib32","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.3390\/foods12193706","article-title":"An Update on the Pivotal Roles of Probiotics, Their Components, and Metabolites in Preventing Colon Cancer","volume":"12","author":"Deng","year":"2023","journal-title":"Foods"},{"key":"10.1016\/j.micres.2026.128682_bib33","article-title":"Gut microbial strain improvement through genetic and metabolic engineering","volume":"1","author":"Dey","year":"2026","journal-title":"Gut Micro Health"},{"key":"10.1016\/j.micres.2026.128682_bib34","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41591-022-01694-6","article-title":"Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial","volume":"28","author":"Dizman","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.micres.2026.128682_bib35","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1186\/s12967-025-07271-y","article-title":"Engineered probiotics: a new era in treating inflammatory bowel disease","volume":"23","author":"Duan","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.micres.2026.128682_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70447","article-title":"Antibiotic Resistance: A Genetic and Physiological Perspective","volume":"6","author":"Elbaiomy","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.micres.2026.128682_bib37","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1016\/S2666-5247(24)00002-8","article-title":"Safety and efficacy of phage application in bacterial decolonisation: a systematic review","volume":"5","author":"Fang","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.micres.2026.128682_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e28407","article-title":"Surviving process and transit: Controlled freeze drying, storage and enteric coated capsules for targeted delivery of probiotic Lactobacillusacidophilus","volume":"10","author":"Fredua-Agyeman","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.micres.2026.128682_bib39","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2026.2634469","article-title":"Temporal dynamics of gut biosynthetic gene clusters link persistent colonization and engraftment in fecal microbiota transplantation","volume":"18","author":"Garcia-Guevara","year":"2026","journal-title":"Gut Microbes"},{"key":"10.1016\/j.micres.2026.128682_bib40","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.3390\/cancers16132478","article-title":"Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells","volume":"16","author":"Garg","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.micres.2026.128682_bib41","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3390\/life14080996","article-title":"Xenobiology for the Biocontainment of Synthetic Organisms: Opportunities and Challenges","volume":"14","author":"G\u00f3mez-Tatay","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.micres.2026.128682_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics18030307","article-title":"Lactococcus lactis as a New Strategy for Oral Vaccination: Current Insights and Future Perspectives","volume":"18","author":"Grossolli-Galvez","year":"2026","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.micres.2026.128682_bib43","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2581445","article-title":"Cross-species engraftment biases and metabolic divergence in gnotobiotic mice humanized with ulcerative colitis microbiota","volume":"17","author":"Guggeis","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.micres.2026.128682_bib44","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.add9667","article-title":"Engineering bacteria as interactive cancer therapies","volume":"378","author":"Gurbatri","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.micres.2026.128682_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001225","article-title":"Plasmid fitness costs are caused by specific genetic conflicts enabling resolution by compensatory mutation","volume":"19","author":"Hall","year":"2021","journal-title":"PLoS. Biol."},{"key":"10.1016\/j.micres.2026.128682_bib46","first-page":"208","article-title":"Engineering strategies to modulate the gut microbiome and immune system","volume":"212","author":"Han","year":"2024","journal-title":"J. Immunol. Baltim. Md 1950"},{"key":"10.1016\/j.micres.2026.128682_bib47","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1974233","article-title":"Tumor hypoxia: an important regulator of tumor progression or a potential modulator of tumor immunogenicity?","volume":"10","author":"Hassan Venkatesh","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.micres.2026.128682_bib48","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.tibtech.2021.08.002","article-title":"Discovery and delivery strategies for engineered live biotherapeutic products","volume":"40","author":"Heavey","year":"2022","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.micres.2026.128682_bib49","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/s41385-022-00564-1","article-title":"Microbiome-based interventions to modulate gut ecology and the immune system","volume":"15","author":"Hitch","year":"2022","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.micres.2026.128682_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms13040913","article-title":"Antibiotic-Resistant Pseudomonas aeruginosa: Current Challenges and Emerging Alternative Therapies","volume":"13","author":"Hu","year":"2025","journal-title":"Microorganisms"},{"key":"10.1016\/j.micres.2026.128682_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2026.106141","article-title":"Oral delivery of GLP-1 analogues by recombinant Lactococcus lactis restores pancreatic islet structure through intestinal mucosal absorption in diabetic mice","volume":"124","author":"Huang","year":"2026","journal-title":"eBioMedicine"},{"key":"10.1016\/j.micres.2026.128682_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens14090874","article-title":"Bacteria-Based Roles in Solid Tumors: Potential for Prevention and Treatment","volume":"14","author":"Huang","year":"2025","journal-title":"Pathogens"},{"key":"10.1016\/j.micres.2026.128682_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2026.115160","article-title":"Systems engineering of engineered live biotherapeutics: A discovery-to-translation framework for streamlining microbiome therapeutic development","volume":"397","author":"Hutchinson","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.micres.2026.128682_bib54","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2015978","article-title":"Quorum Sensing: A Prospective Therapeutic Target for Bacterial Diseases","volume":"2019","author":"Jiang","year":"2019","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.micres.2026.128682_bib55","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2503371","article-title":"Gut microbiota drives structural variation of exogenous probiotics to enhance colonization","volume":"17","author":"Jiang","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.micres.2026.128682_bib56","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2026.2623359","article-title":"Precise probiotic therapy: Advances, bottlenecks, and the road to microbiome-informed nutrition","volume":"18","author":"Jiang","year":"2026","journal-title":"Gut Microbes"},{"key":"10.1016\/j.micres.2026.128682_bib57","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3390\/nu17050845","article-title":"Strategies to Maximize the Benefits of Evidence-Based Enteral Nutrition: A Narrative Review","volume":"17","author":"Kano","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.micres.2026.128682_bib58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s44340-025-00010-5","article-title":"Synthetic biology and application areas","volume":"2","author":"Karata\u015f","year":"2025","journal-title":"Discov. Biotechnol."},{"key":"10.1016\/j.micres.2026.128682_bib59","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.4014\/jmb.2407.07004","article-title":"Synthetic Biology-Driven Microbial Therapeutics for Disease Treatment","volume":"34","author":"Kim","year":"2024","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.micres.2026.128682_bib60","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3390\/metabo15020121","article-title":"Multifluid Metabolomics Identifies Novel Biomarkers for Irritable Bowel Syndrome","volume":"15","author":"Kirk","year":"2025","journal-title":"Metabolites"},{"key":"10.1016\/j.micres.2026.128682_bib61","first-page":"1719","article-title":"Microbiota-Immune Interactions Regulate Metabolic Disease","volume":"207","author":"Klag","year":"2021","journal-title":"J. Immunol. Baltim. Md 1950"},{"key":"10.1016\/j.micres.2026.128682_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1610029","article-title":"Microbiome engineering: unlocking therapeutic potential in inflammatory bowel disease","volume":"16","author":"Kong","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micres.2026.128682_bib63","doi-asserted-by":"crossref","unstructured":"Kothari, M., Wanjari, A., Acharya, S., Karwa, V., Chavhan, R., Kumar, S., Kadu, A., Patil, R.: A Comprehensive Review of Monoclonal Antibodies in Modern Medicine: Tracing the Evolution of a Revolutionary Therapeutic Approach. Cureus. 16, e61983. https:\/\/doi.org\/10.7759\/cureus.61983.","DOI":"10.7759\/cureus.61983"},{"key":"10.1016\/j.micres.2026.128682_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2026.127054","article-title":"Advanced therapeutic strategies and drug delivery approaches for management of oral submucosal fibrosis: a comprehensive review","volume":"700","author":"Kotian","year":"2026","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.micres.2026.128682_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1593334","article-title":"Oral semaglutide for the treatment of obesity: a retrospective real-world study","volume":"16","author":"Krajnc","year":"2025","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.micres.2026.128682_bib66","article-title":"Interplay Between Gut Microbiota and Cholesterol Metabolism in Colorectal Cancer","volume":"27","author":"Li","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micres.2026.128682_bib67","article-title":"Targeting Glycolytic Metabolism in Cancer Therapy: Current Approaches and Future Perspectives","volume":"15","author":"Li","year":"2026","journal-title":"Cells"},{"key":"10.1016\/j.micres.2026.128682_bib68","article-title":"Clinical and biochemical associations of urinary metabolites: quantitative epidemiological approach on renal-cardiometabolic biomarkers","volume":"53","author":"Li","year":"2023","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.micres.2026.128682_bib69","first-page":"164","article-title":"Strategies to mitigate the on- and off-target toxicities of recombinant immunotoxins: an antibody engineering perspective","volume":"5","author":"Li","year":"2022","journal-title":"Antib. Ther."},{"key":"10.1016\/j.micres.2026.128682_bib70","doi-asserted-by":"crossref","DOI":"10.1177\/15330338211036304","article-title":"Hypoxia and the Tumor Microenvironment","volume":"20","author":"Li","year":"2021","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.micres.2026.128682_bib71","doi-asserted-by":"crossref","DOI":"10.1111\/1751-7915.70323","article-title":"Advance Microbiota Transplantation: A Novel Addition\u2013Subtraction Paradigm for Optimising Faecal Microbiota Transplantation","volume":"19","author":"Lin","year":"2026","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.micres.2026.128682_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.171","article-title":"Gut and obesity\/metabolic disease: Focus on microbiota metabolites","volume":"3","author":"Lin","year":"2022","journal-title":"MedComm"},{"key":"10.1016\/j.micres.2026.128682_bib73","article-title":"Use of probiotic lactobacilli in the treatment of vaginal infections: In vitro and in vivo investigations","volume":"13","author":"Liu","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micres.2026.128682_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/life14121676","article-title":"Effects of Several Bile Acids on the Production of Virulence Factors by Pseudomonas aeruginosa","volume":"14","author":"Lomri","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.micres.2026.128682_bib75","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/oby.22700","article-title":"Genetically Engineered Escherichia coli Nissle 1917 Secreting GLP-1 Analog Exhibits Potential Antiobesity Effect in High-Fat Diet-Induced Obesity Mice","volume":"28","author":"Ma","year":"2020","journal-title":"Obesity"},{"key":"10.1016\/j.micres.2026.128682_bib76","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1186\/s12951-024-02901-x","article-title":"Nanotechnology in healthcare, and its safety and environmental risks","volume":"22","author":"Ma","year":"2024","journal-title":"J. Nanobiotechnology."},{"key":"10.1016\/j.micres.2026.128682_bib77","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41392-024-01946-6","article-title":"A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation","volume":"9","author":"Ma","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.micres.2026.128682_bib78","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/6638269","article-title":"Genetically Engineered Microorganisms and Their Impact on Human Health","volume":"2024","author":"Mahdizade Ari","year":"2024","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.micres.2026.128682_bib79","series-title":"Understanding How Monoclonal Antibodies Work","author":"Malik","year":"2026"},{"key":"10.1016\/j.micres.2026.128682_bib80","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fmed.2018.00124","article-title":"Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis","volume":"5","author":"McFarland","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.micres.2026.128682_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115722","article-title":"Advanced Adhesion and Targeting Strategies to Prolong Gut Residence Time and Improve eLBP Efficacy in Colonic Diseases","volume":"227","author":"Miller","year":"2025","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.micres.2026.128682_bib82","doi-asserted-by":"crossref","DOI":"10.4014\/jmb.2410.10054","article-title":"Live Biotherapeutic Products for Metabolic Diseases: Development Strategies, Challenges, and Future Directions","volume":"35","author":"Min","year":"2025","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.micres.2026.128682_bib83","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3390\/nu18030372","article-title":"Prebiotics and Gut Health: Mechanisms, Clinical Evidence, and Future Directions","volume":"18","author":"Monteiro","year":"2026","journal-title":"Nutrients"},{"key":"10.1016\/j.micres.2026.128682_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11020619","article-title":"Gut-on-a-Chip Models: Current and Future Perspectives for Host\u2013Microbial Interactions Research","volume":"11","author":"Morelli","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.micres.2026.128682_bib85","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1038\/s41467-021-23072-5","article-title":"Characterization of an engineered live bacterial therapeutic for the treatment of phenylketonuria in a human gut-on-a-chip","volume":"12","author":"Nelson","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micres.2026.128682_bib86","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41392-024-01866-5","article-title":"Bacterial persisters: molecular mechanisms and therapeutic development","volume":"9","author":"Niu","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.micres.2026.128682_bib87","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1038\/s41467-026-71427-7","article-title":"Beyond metabolic dormancy: metabolic rewiring in bacterial persistence","volume":"17","author":"Orman","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micres.2026.128682_bib88","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1053\/j.seminoncol.2016.07.002","article-title":"Pharmacodynamic Endpoints as Clinical Trial Objectives to Answer Important Questions in Oncology Drug Development","volume":"43","author":"Parchment","year":"2016","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.micres.2026.128682_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2023.101225","article-title":"The Niemann-Pick type diseases \u2013 A synopsis of inborn errors in sphingolipid and cholesterol metabolism","volume":"90","author":"Pfrieger","year":"2023","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.micres.2026.128682_bib90","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/s42255-021-00430-7","article-title":"Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1\/2a study","volume":"3","author":"Puurunen","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.micres.2026.128682_bib91","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.3390\/cancers16172971","article-title":"Towards Understanding Tumour Colonisation by Probiotic Bacterium E. coli Nissle 1917","volume":"16","author":"Radford","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.micres.2026.128682_bib92","unstructured":"Research, C. for B.E. and: VOWST. FDA. (2023)."},{"key":"10.1016\/j.micres.2026.128682_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2025.1560080","article-title":"Leptin, CRP, and adiponectin correlate with body fat percentage in adolescents: systematic review and meta-analysis","volume":"12","author":"Rocha","year":"2025","journal-title":"Front. Nutr."},{"key":"10.1016\/j.micres.2026.128682_bib94","doi-asserted-by":"crossref","first-page":"8464","DOI":"10.1038\/s41598-026-39758-z","article-title":"Bacterial colonization of tumors drives immune activation and checkpoint blockade efficacy","volume":"16","author":"Rolig","year":"2026","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micres.2026.128682_bib95","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s40487-021-00177-x","article-title":"Bacterial-Based Methods for Cancer Treatment: What We Know and Where We Are","volume":"10","author":"Rommasi","year":"2022","journal-title":"Oncol. Ther."},{"key":"10.1016\/j.micres.2026.128682_bib96","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ccell.2023.12.003","article-title":"Melanoma and microbiota: Current understanding and future directions","volume":"42","author":"Routy","year":"2024","journal-title":"Cancer Cell."},{"key":"10.1016\/j.micres.2026.128682_bib97","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.3390\/vaccines13121222","article-title":"Engineering Anti-Tumor Immunity: An Immunological Framework for mRNA Cancer Vaccines","volume":"13","author":"Roy","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.micres.2026.128682_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.1000873","article-title":"Microbiome engineering: engineered live biotherapeutic products for treating human disease","volume":"10","author":"Rutter","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.micres.2026.128682_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1161521","article-title":"Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments","volume":"14","author":"Ruze","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.micres.2026.128682_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114543","article-title":"vitro and ex vivo models for evaluating vaginal drug delivery systems","volume":"191","author":"Shapiro","year":"2022","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.micres.2026.128682_bib101","doi-asserted-by":"crossref","DOI":"10.3390\/nu18101540","article-title":"Gut Microbiome Dysbiosis in Metabolic Syndrome: Current Evidence and Emerging Perspectives","volume":"18","author":"Shehata","year":"2026","journal-title":"Nutrients"},{"key":"10.1016\/j.micres.2026.128682_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1219763","article-title":"Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles modulate the intestinal microbiome and host gut-liver metabolome in obese and diabetic mice","volume":"14","author":"Shi","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micres.2026.128682_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.fochx.2026.103802","article-title":"Encapsulation of probiotics to improve their survival: A focus on Bifidobacterium animalis subsp. lactis BB-12","volume":"35","author":"Shu","year":"2026","journal-title":"Food Chem. X."},{"key":"10.1016\/j.micres.2026.128682_bib104","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.trecan.2020.11.004","article-title":"Tweak to Treat: Reprograming Bacteria for Cancer Treatment","volume":"7","author":"Sieow","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.micres.2026.128682_bib105","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12934-024-02370-9","article-title":"\u201cMetabolic burden\u201d explained: stress symptoms and its related responses induced by (over)expression of (heterologous) proteins in Escherichia coli","volume":"23","author":"Snoeck","year":"2024","journal-title":"Microb. Cell. Factor."},{"key":"10.1016\/j.micres.2026.128682_bib106","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.semcancer.2024.03.003","article-title":"Hypoxia-Targeting Bacteria in Cancer Therapy","volume":"100","author":"Staedtke","year":"2024","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.micres.2026.128682_bib107","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/19490976.2019.1586039","article-title":"Probiotics in the next-generation sequencing era","volume":"11","author":"Suez","year":"2019","journal-title":"Gut Microbes"},{"key":"10.1016\/j.micres.2026.128682_bib108","unstructured":"Synlogic: A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, and Pharmacodynamics of SYNB1020 in Hepatic Insufficiency and Cirrhosis Patients. clinicaltrials.gov (2021)."},{"key":"10.1016\/j.micres.2026.128682_bib109","unstructured":"Synlogic: A Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, and Pharmacodynamics of SYNB8802 in Healthy Volunteers and in Patients With Enteric Hyperoxaluria. clinicaltrials.gov (2024)."},{"key":"10.1016\/j.micres.2026.128682_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1688057","article-title":"Antibody\u2013drug conjugate: a newly developed biological missile for tumor treatment","volume":"15","author":"Tang","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.micres.2026.128682_bib111","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/biotech10030014","article-title":"Applications of CRISPR-Cas9 as an Advanced Genome Editing System in Life Sciences","volume":"10","author":"Tavakoli","year":"2021","journal-title":"BioTech"},{"key":"10.1016\/j.micres.2026.128682_bib112","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.819336","article-title":"Probiotic Escherichia coli Nissle 1917 Expressing Elafin Protects Against Inflammation and Restores the Gut Microbiota","volume":"13","author":"Teng","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micres.2026.128682_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9051021","article-title":"Role of Gut Microbiota and Probiotics in Colorectal Cancer: Onset and Progression","volume":"9","author":"Torres-Maravilla","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.micres.2026.128682_bib114","unstructured":"University of Chicago: Phase II Dual-Cohort Study Evaluating the Effects of Pembrolizumab in the Presence of Gut Microbiota Modulation With EDP1503 in Advanced Melanoma Na\u00efve or Refractory to Anti-PD1 Antibody. clinicaltrials.gov (2025)."},{"key":"10.1016\/j.micres.2026.128682_bib115","article-title":"Nanovaccines in cancer immunoprevention and immunotherapy: Current insights and future directions","volume":"47","author":"Uti","year":"2026","journal-title":"Cancer Treat. Res. Commun."},{"key":"10.1016\/j.micres.2026.128682_bib116","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s11671-025-04248-0","article-title":"Antioxidants in cancer therapy mitigating lipid peroxidation without compromising treatment through nanotechnology","volume":"20","author":"Uti","year":"2025","journal-title":"Discov. Nano."},{"key":"10.1016\/j.micres.2026.128682_bib117","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71519","article-title":"Theranostic Nanoparticles in Prostate Cancer: Disrupting Hypoxia-Induced Glycolysis by Targeting Hypoxia-Inducible Factor-1 Alpha and Downstream Metabolites","volume":"15","author":"Uti","year":"2026","journal-title":"Cancer Med."},{"key":"10.1016\/j.micres.2026.128682_bib118","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/v11010010","article-title":"Interactions between Bacteriophage, Bacteria, and the Mammalian Immune System","volume":"11","author":"Van Belleghem","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.micres.2026.128682_bib119","unstructured":"Vedanta Biosciences, Inc.: CONSORTIUM - A Double-Blind Placebo-Controlled Phase 2 Study of VE303 for Prevention of Recurrent Clostridium (Clostridioides) Difficile Infection. clinicaltrials.gov (2023)."},{"key":"10.1016\/j.micres.2026.128682_bib120","article-title":"The Gut Gambit: A Review of How Microbial Imbalance Fuels Metabolic Mayhem","volume":"18","author":"Venkata","year":"2026","journal-title":"Nutrients"},{"key":"10.1016\/j.micres.2026.128682_bib121","doi-asserted-by":"crossref","DOI":"10.3390\/ph19030454","article-title":"Biomarker-Guided Drug Delivery Systems and Oral Bioavailability Enhancement","volume":"19","author":"Vo","year":"2026","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.micres.2026.128682_bib122","first-page":"633","article-title":"Gut Microbiota-Based Immunotherapy: Engineered Escherichia coli Nissle 1917 for Oral Delivery of Glypican-1 in Pancreatic Cancer","volume":"61","author":"Vruzhaj","year":"2025","journal-title":"Med. (Mex. )."},{"key":"10.1016\/j.micres.2026.128682_bib123","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s10637-025-01573-0","article-title":"Phase 1\/2, open-label study of oral bacterial supplementation (EDP1503) plus pembrolizumab in participants with advanced or metastatic microsatellite-stable colorectal cancer, triple-negative breast cancer, and checkpoint inhibitor\u2013relapsed tumors","volume":"43","author":"Wang","year":"2025","journal-title":"Invest. New. Drugs"},{"key":"10.1016\/j.micres.2026.128682_bib124","article-title":"Strategies for overcoming multiple barriers of oral administration of protein and peptide therapeutics","volume":"37","author":"Wang","year":"2026","journal-title":"Mater. Today Bio."},{"key":"10.1016\/j.micres.2026.128682_bib125","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13045-025-01766-3","article-title":"Engineering bacteria for enhanced tumor therapy: from surface modification to synthetic genetic circuits","volume":"19","author":"Wang","year":"2025","journal-title":"J. Hematol. Oncol. J. Hematol. Oncol."},{"key":"10.1016\/j.micres.2026.128682_bib126","article-title":"Probiotic-mediated tumor microenvironment reprogramming with protease-sensitive interleukin-15 and photothermal therapy","volume":"6","author":"Wang","year":"2025","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.micres.2026.128682_bib127","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13036-018-0105-8","article-title":"Auxotrophy to Xeno-DNA: an exploration of combinatorial mechanisms for a high-fidelity biosafety system for synthetic biology applications","volume":"12","author":"Whitford","year":"2018","journal-title":"J. Biol. Eng."},{"key":"10.1016\/j.micres.2026.128682_bib128","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ymthe.2025.11.013","article-title":"Recent advances of engineered bacteria for therapeutic applications","volume":"34","author":"Xiang","year":"2026","journal-title":"Mol. Ther."},{"key":"10.1016\/j.micres.2026.128682_bib129","article-title":"Current understanding of the intratumoral microbiome in various tumors","volume":"4","author":"Xue","year":"2023","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.micres.2026.128682_bib130","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1038\/s41591-019-0626-9","article-title":"Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients","volume":"25","author":"Yelin","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.micres.2026.128682_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtbio.2026.103020","article-title":"Endogenous Living Adjuvants for Cancer Vaccination: Concepts, Mechanisms, and Design Principles","author":"Yu","year":"2026","journal-title":"Mater. Today Bio."},{"key":"10.1016\/j.micres.2026.128682_bib132","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3934\/microbiol.2025042","article-title":"Engineered bacteria as living therapeutics: Next-generation precision tools for health, industry, environment, and agriculture","volume":"11","author":"Zalila-Kolsi","year":"2025","journal-title":"AIMS Microbiol."},{"key":"10.1016\/j.micres.2026.128682_bib133","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.fmre.2024.11.001","article-title":"Engineered bacteria: Strategies and applications in cancer immunotherapy","volume":"5","author":"Zhang","year":"2025","journal-title":"Fundam. Res."},{"key":"10.1016\/j.micres.2026.128682_bib134","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41392-023-01375-x","article-title":"Synthetic biology-inspired cell engineering in diagnosis, treatment and drug development","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.micres.2026.128682_bib135","doi-asserted-by":"crossref","DOI":"10.1093\/lifemeta\/load032","article-title":"Gut microbiota, immunity, and bile acid metabolism: decoding metabolic disease interactions","volume":"2","author":"Zhao","year":"2023","journal-title":"Life Metab."},{"key":"10.1016\/j.micres.2026.128682_bib136","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.micres.2026.128682_bib137","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.3390\/pharmaceutics15092214","article-title":"Bacterial Drug Delivery Systems for Cancer Therapy: \u201cWhy\u201d and \u201cHow.\u201d","volume":"15","author":"Zhao","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.micres.2026.128682_bib138","article-title":"Programmable microbial therapeutics: advances in engineered bacteria for targeted in vivo delivery and precision medicine","author":"Zhao","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.micres.2026.128682_bib139","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s43556-025-00303-5","article-title":"Metabolic syndrome: molecular mechanisms and therapeutic interventions","volume":"6","author":"Zheng","year":"2025","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.micres.2026.128682_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122304","article-title":"Review on chronic metabolic diseases surrounding bile acids and gut microbiota: What we have explored so far","volume":"336","author":"Zhu","year":"2024","journal-title":"Life Sci."}],"container-title":["Microbiological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944501326002466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944501326002466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T08:44:41Z","timestamp":1788684281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944501326002466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":140,"alternative-id":["S0944501326002466"],"URL":"https:\/\/doi.org\/10.1016\/j.micres.2026.128682","relation":{},"ISSN":["0944-5013"],"issn-type":[{"value":"0944-5013","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetic biology strategies for engineering microbial therapeutics in metabolic diseases and cancer","name":"articletitle","label":"Article Title"},{"value":"Microbiological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micres.2026.128682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128682"}}